Stephen Huhn
Hoofd Techniek/Wetenschap/O&O bij CONTINEUM THERAPEUTICS, INC.
Vermogen: - $ op 31-05-2024
Actieve functies van Stephen Huhn
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2020 | - |
Loopbaan van Stephen Huhn
Eerdere bekende functies van Stephen Huhn
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
StemCells, Inc.
 StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Hoofd Techniek/Wetenschap/O&O | 17-06-2014 | - |
| Corporate Officer/Principal | 01-01-2007 | 17-06-2014 | |
| Stanford University | Corporate Officer/Principal | - | - |
Opleiding van Stephen Huhn
| University of Arizona | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectoraal
| Consumer Services | 3 |
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CONTINEUM THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Health Technology |
- Beurs
- Insiders
- Stephen Huhn
- Ervaring
